Related Experiment Video
Updated: Jun 29, 2026

Assessing Changes in Volatile General Anesthetic Sensitivity of Mice after Local or Systemic Pharmacological Intervention
Published on: October 16, 2013
Antimicrobial effects of two anaesthetic agents: dexmedetomidine and midazolam
1Departments of Anesthesiology and Reanimation, Karaelmas University School of Medicine, Zonguldak, Turkey.
Abstract:
Some anaesthetic agents are known to inhibit microbial growth. The aim of this in vitro study was to investigate possible antimicrobial effects of two frequently used agents in intensive care units, dexmedetomidine and midazolam. Antimicrobial effect was tested on Staphylococcus aureus, Enterococcus faecalis, Escherichia coli and Pseudomonas aeruginosa by broth microdilution method. Midazolam showed inhibitor and bactericidal effect on S. aureus at concentrations 256 mmicrog x ml(-1) and 512/microg x ml(-1) respectively and on E. faecalis at concentrations 128 microg x ml(-1) and 256 microg x ml(-1). Dexmedetomidine demonstrated inhibitor effect on S. aureus, E. coli and P aeruginosa at concentrations 32 microg x ml(-1), 16 microg x ml(-1) and 16 microg x ml(-1) respectively. Midazolam had inhibitor and bactericidal effects on S. aureus and E. faecalis. Dexmedetomidine had only inhibitor effects on S. aureus, E. coli and P aeruginosa. Further studies are needed to determine the antimicrobial mechanisms and clinical applications.
Insights
Midazolam and dexmedetomidine, common anesthetic agents, show antimicrobial properties against bacteria like Staphylococcus aureus. Midazolam exhibited both inhibitory and bactericidal effects, while dexmedetomidine demonstrated only inhibitory effects in vitro.
Area of Science:
- Microbiology
- Pharmacology
- Intensive Care Medicine
Background:
- Anesthetic agents can possess antimicrobial properties.
- Dexmedetomidine and midazolam are frequently used in intensive care units (ICUs).
Purpose of the Study:
- To investigate the in vitro antimicrobial effects of dexmedetomidine and midazolam.
- To determine the spectrum of activity and types of antimicrobial action (inhibition vs. bactericidal).
Main Methods:
- Broth microdilution method was employed.
- Antimicrobial activity was tested against Staphylococcus aureus, Enterococcus faecalis, Escherichia coli, and Pseudomonas aeruginosa.
Main Results:
- Midazolam demonstrated inhibitory and bactericidal effects on S. aureus and E. faecalis at specific concentrations.
- Dexmedetomidine showed inhibitory effects on S. aureus, E. coli, and P. aeruginosa at lower concentrations.
- Different bacterial species exhibited varying susceptibility to the agents.
Conclusions:
- Both midazolam and dexmedetomidine exhibit antimicrobial activity in vitro.
- Midazolam possesses both inhibitory and bactericidal properties, whereas dexmedetomidine's effects appear primarily inhibitory.
- Further research is warranted to elucidate antimicrobial mechanisms and potential clinical applications.
Related Concept Videos
Parenteral Anesthetics: Overview
Inhalational Anesthetics: Overview
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Stages of General Anesthesia
Skeletal Muscle Relaxants: Therapeutic Uses
Sedatives and Hypnotics Drugs: Benzodiazepines
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
